Who Owns Clover Health Company?

Clover Health Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Clover Health?

Clover Health, a tech-driven healthcare company, has undergone a fascinating transformation since its inception. Understanding the Clover Health SWOT Analysis is key, but first, let's unravel the complex web of Clover Health ownership. Knowing who owns Clover Health is critical for investors, analysts, and anyone tracking the Medicare Advantage market. This knowledge provides insights into the company's strategic direction and future prospects.

From its founding by Vivek Garipalli and Kris Gale to its public debut via a SPAC merger, the Clover Health company profile reveals a dynamic ownership journey. This article will explore the evolution of Clover Health ownership structure, examining its major shareholders, Clover Health investors, and the influence of its Clover Health executives and Clover Health leadership team. We'll also investigate the Clover Health board of directors and the impact of Clover Health insider ownership on the company's strategy.

The story of Clover Health begins with its co-founders, Vivek Garipalli and Kris Gale, who launched the company in 2014. Garipalli, a seasoned healthcare entrepreneur, brought experience from his previous ventures, while Gale contributed his expertise from the tech world, specifically from his time at Yammer. This combination of healthcare and tech backgrounds set the stage for Clover Health's innovative approach to health insurance.

Early financial backing played a crucial role in shaping Clover Health's ownership structure. Initial funding rounds brought in significant investments, providing the capital needed to grow and expand. These early investments not only fueled the company's operations but also influenced the composition of its board and the overall direction of the company.

Understanding the founders' and early investors' roles is essential for grasping the company's evolution. The initial ownership structure, which evolved over time, reflects the confidence and strategic vision of its backers. This early support was instrumental in the company's journey toward becoming a publicly listed entity.

Key Players and Early Investments

The early ownership of Clover Health involved key figures and significant investment rounds. First Round Capital led the Series A round in September 2015, which raised $100 million. By 2017, the company had amassed a total of $425 million across five funding rounds, reaching a valuation of over $1.2 billion. These early investments shaped the company's trajectory and ownership landscape.

• Clover Health was co-founded in 2014 by Vivek Garipalli and Kris Gale.
• The Series A round in September 2015 was led by First Round Capital.
• By 2017, total funding reached $425 million across five rounds.
• Notable early investors included Sequoia Capital and GV.

Clover Health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of Clover Health underwent a significant shift when it became a publicly traded company on January 8, 2021. This was achieved through a Special Purpose Acquisition Company (SPAC) merger with Social Capital Hedosophia Holdings Corp. III (SCH). This transaction valued Clover Health at $3.7 billion. The deal included a Private Investment in Public Equity (PIPE) offering, which involved the sale of 40 million shares of Class A stock at $10 per share.

The SPAC merger and subsequent PIPE offering brought in investments from key figures. SCH CEO Chamath Palihapitiya invested $100 million, and Hedosophia contributed $50 million. Existing investors, such as Fidelity, also participated. This influx of capital and the transition to a public company significantly altered the composition of Clover Health's shareholder base and its overall financial standing.

As of August 2024, Co-founder and Executive Chairman Vivek Garipalli held approximately 88.8 million Class B shares. These shares provide him with significant voting power. While institutional investors are major shareholders, in 2021, they held only 10% of the total shares, indicating a large portion was held by retail investors. Detailed information on and can be found in SEC filings and annual reports.

Key Takeaways on Clover Health Ownership

Clover Health's ownership structure has evolved significantly since going public.

• The SPAC merger was a pivotal event.
• Vivek Garipalli holds substantial voting power.
• Institutional ownership is significant, but retail investors also play a role.
• Understanding the is crucial for investors.

Clover Health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current Clover Health board of directors significantly influences the company's governance. The company's structure includes a dual-class share system, affecting voting rights. As of April 15, 2024, Class A common stock holders have one vote per share, while Class B holders have ten votes per share. This structure concentrates voting power among specific stockholders, including directors, executives, principal stockholders, and their affiliates.

This structure means that certain individuals and entities wield considerable influence over Clover Health. For instance, as of December 31, 2021, these groups collectively held 81.8% of the total voting power. The election of board members requires a plurality of votes, and the existing voting structure enables holders of a majority of the outstanding Class A and Class B common stock to elect all directors. Information about specific board members representing major shareholders or their independence is available in SEC proxy statements.

Co-founder and Executive Chairman Vivek Garipalli, due to his substantial Class B share holdings, has a disproportionate amount of voting power. His Class B shares will automatically convert to Class A shares on the earliest of January 7, 2031, the separation date of the last of the founders (Vivek Garipalli and Andrew Toy), or one year after the death or permanent disability of the last founder. The annual meeting of stockholders was held virtually on June 10, 2025, where stockholders voted on various proposals. There have been no significant proxy battles or activist investor campaigns in the 2024-2025 timeframe that have altered the decision-making framework, beyond the influence of the dual-class share structure.

Understanding Clover Health's Ownership

Clover Health's ownership structure is complex, with a dual-class share system impacting voting rights. This system concentrates voting power, primarily with the founders and early investors. This structure influences the company's strategic decisions and governance.

• Class A shares: One vote per share.
• Class B shares: Ten votes per share.
• Key individuals and entities held 81.8% of the total voting power as of December 31, 2021.
• The dual-class structure affects the influence of Clover Health investors and Clover Health executives.

Clover Health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, significant developments have shaped the ownership landscape of Clover Health. Recent insider activity indicates continued confidence in the company. For instance, in August 2024, co-founder and Executive Chairman Vivek Garipalli purchased over $1 million worth of stock, increasing his Class A shareholdings. Director Anna Loengard also acquired shares in May 2024. These actions suggest a positive outlook from key regarding the company's future.

The company has also strategically utilized inducement grants of restricted stock units (RSUs) to attract and retain talent. In April 2024, Peter Kuipers, the new Chief Financial Officer, received over 4.2 million shares of Class A Common Stock. Another grant was made in February 2024 for over 900,000 shares. While these grants dilute existing ownership, they are crucial for attracting top-tier personnel and supporting ’s growth initiatives. This approach is a common practice among public companies to incentivize employees and align their interests with those of the shareholders.

Financially, has shown improvement. The GAAP Net loss from continuing operations narrowed to $46 million in 2024, a significant improvement from $210 million in 2023. Adjusted EBITDA profitability reached $70 million in 2024, a substantial increase from a $42 million loss in 2023. In 2025, the company projects average Medicare Advantage membership of 103,000 - 107,000, representing a 30% growth year-over-year, and insurance revenue between $1.800 billion and $1.875 billion, a 37% growth at the midpoint. The company anticipates adjusted EBITDA profitability between $50 million and $70 million for 2025. These financial results and projections are important for and indicate a positive trajectory.

In 2024, launched Counterpart Health, a subsidiary that offers its Clover Assistant technology to external payors and providers. This expansion strategy, along with the company's focus on technology-driven care management and achieving profitability, suggests a continued strategy of growth and operational efficiency. As of June 13, 2025, the stock price was $2.88, with a market cap of $1.47 billion, reflecting the market's valuation of the company. These factors will likely influence future trends and investor sentiment.

Ownership Structure

The ownership structure of is influenced by insider activity, inducement grants, and the overall financial performance of the company. The company is a public company, and its shares are traded on the Nasdaq stock exchange.

Key Personnel Impact

Key personnel, such as Vivek Garipalli and new hires like Peter Kuipers, significantly impact through stock purchases and grants. Their actions signal confidence and influence investor sentiment.

Financial Performance

The company's improving financial performance, including reduced losses and projected revenue growth, is a key factor influencing trends. These improvements attract and retain investors.

Future Outlook

With the launch of Counterpart Health and a focus on technology and profitability, is poised for continued growth, which will likely impact future ownership trends and investor sentiment. The company's strategic moves are crucial.

Clover Health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs